In the Journals

Naloxone coprescription laws may lead to more than 7-fold increase in dispensing

June 21, 2019
Legally mandating naloxone coprescriptions for patients at high risk for opioid overdose was tied to a 7.75-fold increase in dispensed naloxone…

In the Journals

Improved dietary guidance, vitamin supplements needed for pregnant women

June 21, 2019
A significant number of pregnant women in the United States did not consume enough of some essential nutrients, but consumed too much of others…

In the Journals

Typical antipsychotics may not increase stroke risk in younger patients

June 20, 2019
Results from a retrospective comparative study did not indicate an increased risk for stroke in typical vs. atypical antipsychotic users in a…

In the Journals

Further adherence assessment needed in patients with apparent treatment-resistant hypertension

June 19, 2019
Physicians often fail to confirm treatment adherence in patients with apparent treatment-resistant hypertension, suggesting that physicians cannot…

Point/Counter

Should the US government leverage patents held by the CDC to push down the price of Truvada?

Infectious Diseases in Children, June 2019
POINT. The federal government should sue Gilead to enforce its patents on PrEP and lower the price of the treatment. I am impressed by the fact that…

Meeting News

AMA passes policies to end non-opioid treatment barriers

June 13, 2019
The AMA approved multiple opioid-related policies at their annual meeting that aim to make patients the focus of pain treatment rather than third…

Meeting News

More than half of patients with arthritis report CBD use

June 12, 2019
Nearly 60% of patients with arthritis reported using cannabidiol products to relieve pain and other symptoms despite limited evidence showing…

In the Journals

Sodium polystyrene sulfonate use tied to increased risk for adverse GI events

June 11, 2019
Sodium polystyrene sulfonate, a common treatment for hyperkalemia, was associated with an increased risk for serious adverse gastrointestinal events…

Meeting News

Ertugliflozin, oral semaglutide produce positive results in type 2 diabetes

June 11, 2019
SAN FRANCISCO — The SGLT2 inhibitor ertugliflozin and an oral version of the GLP-1 receptor agonist semaglutide demonstrated favorable results…

Feature

Battle for Enbrel: Ruling on patent lawsuit could transform US biosimilar marketplace

June 10, 2019
Amgen is currently embroiled in two pivotal court cases surrounding patents for its bestselling etanercept product that could protect it from…

In the Journals

Researchers debunk claim that medical marijuana is solution to opioid crisis

June 10, 2019
Legalization of medical cannabis did not reduce the rate of opioid overdose deaths, according to a report recently published in the Proceedings of

In the Journals

MDMA-assisted psychotherapy effective, well-tolerated in PTSD

June 10, 2019
Pooled data from six phase 2 randomized controlled trials support the use of MDMA plus psychotherapy for the treatment of PTSD. In 2017, the

FDA News

FDA approves first drug for episodic cluster headache

June 5, 2019
The FDA approved Emgality for treatment of episodic cluster headache in adults. Emgality (galcanezumab-gnlm, Eli Lilly) is the first drug approved…

FDA News

FDA receives ‘substantial’ response to information request on CBD

June 3, 2019
About 100 people provided an FDA panel with study data, real-life anecdotes or proposed ideas, as it establishes regulatory framework for…

Feature

FDA encourages physicians to educate patients on acetaminophen formulations to reduce risk of overdose

May 23, 2019
Acetaminophen-related overdose continues to be a leading cause of ED visits and hospitalizations and remains the leading cause of drug-induced acute…

FDA News

FDA approves novel epilepsy drug

May 22, 2019
UCB announced that its benzodiazepine-based nasal spray for patients with epilepsy was recently approved by the FDA. “Treating seizure…

Meeting News

Fitbits may predict relapse in patients with IBD

May 21, 2019
SAN DIEGO — Fitbits proactively monitored some components of inflammatory bowel disease that could lead to the condition’s relapse…

Meeting News

Entyvio ‘superior’ to Humira in certain ulcerative colitis cases

May 21, 2019
SAN DIEGO — Clinical and endoscopic outcomes of Entyvio treatment were “superior” to those of Humira in cases of moderately to…

Meeting NewsPerspective

Next-generation antidepressants show promise for treatment-resistant disease

May 19, 2019
SAN FRANCISCO — In a session here, experts discussed advances in the understanding and treatment of treatment-resistant depression.

Pharmacology Consult

Is your patient ‘allergic’ to penicillin? Perhaps not

Infectious Diseases in Children, May 2019
Edward A. Bell, PharmD, BCPS
As readers of Infectious Diseases in Children are well aware, it is not uncommon to hear “penicillin” when parents are asked…